BEDUA Trademark

Trademark Overview

On Tuesday, January 15, 2008, a trademark application was filed for BEDUA with the United States Patent and Trademark Office. The USPTO has given the BEDUA trademark a serial number of 77372365. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 13, 2012. This trademark is owned by Glaxo Group Limited. The BEDUA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for oral or topical use only for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, excluding pharmaceutical preparations and substances for the prevention and treatment of cancer; Pharmaceutical preparations and substances for oral or topical use only for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, excluding pharmaceutical preparations and substances for the prevention and treatment of cancer; Pharmaceutical preparations and substances for oral or topical use only for the treatment of damaged skin and tissue, excluding pharmaceutical preparations and substances for the prevention and treatment of cancer
bedua

General Information

Serial Number77372365
Word MarkBEDUA
Filing DateTuesday, January 15, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 13, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for oral or topical use only for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, excluding pharmaceutical preparations and substances for the prevention and treatment of cancer; Pharmaceutical preparations and substances for oral or topical use only for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, excluding pharmaceutical preparations and substances for the prevention and treatment of cancer; Pharmaceutical preparations and substances for oral or topical use only for the treatment of damaged skin and tissue, excluding pharmaceutical preparations and substances for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 22, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, August 13, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 13, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 13, 2012EXTENSION 5 GRANTED
Thursday, January 5, 2012EXTENSION 5 FILED
Thursday, January 5, 2012TEAS EXTENSION RECEIVED
Tuesday, June 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 26, 2011EXTENSION 4 GRANTED
Thursday, June 23, 2011EXTENSION 4 FILED
Thursday, June 23, 2011TEAS EXTENSION RECEIVED
Tuesday, December 14, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 12, 2010EXTENSION 3 GRANTED
Wednesday, November 24, 2010EXTENSION 3 FILED
Wednesday, November 24, 2010TEAS EXTENSION RECEIVED
Saturday, June 26, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 25, 2010EXTENSION 2 GRANTED
Wednesday, June 2, 2010EXTENSION 2 FILED
Friday, June 25, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 2, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 22, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 22, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 10, 2009EXTENSION 1 GRANTED
Thursday, December 10, 2009EXTENSION 1 FILED
Thursday, December 10, 2009TEAS EXTENSION RECEIVED
Tuesday, July 14, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2009NOTICE OF PUBLICATION
Thursday, March 19, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 5, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 5, 2009ASSIGNED TO LIE
Wednesday, February 4, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 15, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 15, 2008NON-FINAL ACTION E-MAILED
Friday, August 15, 2008NON-FINAL ACTION WRITTEN
Wednesday, July 30, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 30, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 30, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 22, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 27, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, April 27, 2008NON-FINAL ACTION E-MAILED
Sunday, April 27, 2008NON-FINAL ACTION WRITTEN
Monday, April 21, 2008ASSIGNED TO EXAMINER
Tuesday, January 22, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

bedua treatment substances preparations pharmaceutical disorders prevention cancer only oral topical